Ruthenium-106 Brachytherapy in Treatment of Uveal Melanoma: 50 Years of Use!

BIO Web of Conferences
doi 10.1051/bioconf/20191407005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

EDP Sciences

Related search

Endoresection With Adjuvant Ruthenium Brachytherapy for Selected Uveal Melanoma Patients - The Tuebingen Experience

Acta Ophthalmologica
MedicineOphthalmology
2016English

Comparison of Iodide-125 and Ruthenium-106 Brachytherapy in the Treatment of Choroidal Melanomas

Clinical Ophthalmology
Ophthalmology
2020English

Nanoparticles for Uveal Melanoma Treatment

2008English

Treatment of Uveal Melanoma: An Oncologist's View

Acta Ophthalmologica
MedicineOphthalmology
2018English

Does Ocular Treatment of Uveal Melanoma Influence Survival?

British Journal of Cancer
Cancer ResearchOncology
2010English

Obstacles to Improving Outcomes in the Treatment of Uveal Melanoma

Cancer
Cancer ResearchOncology
2018English

Gamma Knife Radiosurgery for Uveal Melanoma Ineligible for Brachytherapy by the Collaborative Ocular Melanoma Study Criteria

Open Access Surgery
Sports MedicineAnesthesiologyTransplantationOrthopedicsSurgeryPain Medicine
2008English

Post-Brachytherapy Initial Tumour Regression Rate Correlates With Metastatic Spread in Posterior Uveal Melanoma

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2004English

Immunoexpression of Macroh2a in Uveal Melanoma

Applied Sciences (Switzerland)
InstrumentationMaterials ScienceFluid FlowEngineeringComputer Science ApplicationsProcess ChemistryTransfer ProcessesTechnology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy